{"id":"W2954391632","doi":"10.1200/jco.2019.37.15_suppl.tps7063","title":"MIRROS: An ongoing randomized phase 3 trial of idasanutlin + ARA-C in patients with relapsed or refractory acute myeloid leukemia.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Interim analysis; Clinical endpoint; Oncology; Refractory (planetary science); Population; Phases of clinical research; Hematopoietic stem cell transplantation; Transplantation; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001279007,0.001854742,0.001878842,0.0004277982,0.0003865877,0.0009522258,0.0009704303,0.001347743,0.01036862],"category_scores_gemma":[0.001013299,0.000529291,0.00155581,0.00034748,0.0008940469,0.0008723679,0.000435074,0.003199882,0.001767255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007139467,"about_ca_system_score_gemma":0.001441101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008882433,"about_ca_topic_score_gemma":0.003176753,"domain_scores_codex":[0.9996799,0.0001749467,0.00001347163,0.00004879415,0.00003216238,0.00005076736],"domain_scores_gemma":[0.9995368,0.0000834679,0.0001259427,0.0000310074,0.00003080708,0.0001919554],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.942302,0.009857638,0.0009510224,0.0009860017,0.000776233,0.00007624613,0.00008184127,0.0005877604,0.006724364,0.0003434996,0.003444817,0.03386867],"study_design_scores_gemma":[0.9178533,0.07725992,0.001550742,0.00004807507,0.0002424691,0.00007210787,0.00003253353,0.0003080115,0.0003795195,0.0002297292,0.002011401,0.00001222238],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9627076,0.008758265,0.001174315,0.002378945,0.00103975,0.01136031,0.004129637,0.0004249419,0.00802624],"genre_scores_gemma":[0.9531435,0.007924075,0.004557215,0.004562611,0.0007897462,0.01269037,0.006232937,0.00008106552,0.01001841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01036862,"threshold_uncertainty_score":0.03468645,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07389082348103082,"score_gpt":0.4581241315676492,"score_spread":0.3842333080866184,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}